An intensive workshop providing a substantive overview of molecular biology, translational cancer research, current lab techniques, career development, and the best practices of grant writing for the aspiring physician-scientist.
An intensive workshop in the essentials of effective clinical trial designs of therapeutic interventions in the treatment of cancer for clinical fellow and junior faculty clinical researchers in all oncology sub-specialties, including radiation and surgical oncology and radiology.
Back to Bedside is designed to empower residents and fellows to develop transformative projects that foster meaning and joy in work and allow them to engage on a deeper level with what is at the heart of medicine: their patients. Supported by the ACGME, Back to Bedside provides a competitive funding opportunity for resident- and/or fellow-led teams to innovate. The initiative is also intended to create a learning collaborative of resident-/fellow-led research teams.
The Global Oncology Young Investigator Award (GO YIA) provides research funding to early-career investigators to encourage and promote quality research in global oncology and to develop the next generation of researchers to address global health needs. Global oncology is a general term that refers to the application of the concepts of global health to cancer, and implies an approach to the practice of oncology that acknowledges the reality of limited resources in most parts of the world.
The ASCO Journals Editorial Fellowship is designed to introduce oncology fellows (or their local equivalent) to the peer review, editing and publishing of medical research manuscripts in journals.
Applicants must be a fellow in training or no more than 1 year out of training, and must be in the field of oncology. Successful applicants will also have some experience publishing papers, and will have specific ideas for what they hope to learn in the program.
The Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this grant is to fund physicians during the transition from a fellowship program to a faculty appointment. Applications in all areas of cancer research are accepted from U.S. and international applicants.
The YIA is a one-year grant totaling $50,000 that supports personnel and/or research expenses, and travel to attend the Conquer Cancer Grants & Awards Ceremony at the ASCO Annual Meeting. Applicants who are selected to receive a YIA are allowed to receive other grants from other funding agencies.
The ASH Clinical Research Training Institute (CRTI) is a unique, year-long education and mentoring program for hematology fellows and junior faculty at academic medical centers. CRTI offers a broad education on clinical research methods, research collaborations, statistical analysis, and managing the demands of family and career. The goal of the program is to produce leaders armed with ideas for clinical hematology research and the tools and resources to make their ideas a reality.
The ASH Graduate Hematology Award encourages graduate students in the United States and Canada to pursue a career in academic hematology. The award provides funding for students conducting research on hematology-focused projects and is open to doctoral students in their first, second, or third year of graduate school at the time of application.
The ASH Hematology Review Series is designed for fellows preparing to take the internal medicine hematology certification exam or those desiring a comprehensive update of hematology standards of care. This series provides a free review of hematology patterned after the American Board of Internal Medicine (ABIM) Certification Examination Blueprint.
The ASH Minority Recruitment Initiative (MRI) was created in 2003 to increase the participation of underrepresented minorities training in hematology-related fields and to increase the number of minority hematologists with academic and research appointments.
A six-week short course in basic clinical trial methodology. Schedule of topics include: study design history and comparisons, sample size, power, and sequential monitoring, novel study designs and reporting results, etc.
The objective of the Leaders in Informatics, Quality and Systems (LInQS) Fellowship Program is to develop CUSOM Department of Medicine fellows and faculty into future leaders with successful academic careers in the areas of quality improvement (QI), clinical system design, clinical informatics, and/or patient safety.
This elective runs twice per year, May and December
Director: Eric Young, MD
This elective covers four weeks – three weeks of classes combined with one week of vacation or other activities assigned by the participant’s training program.
18 participants are enrolled per session on a first-come, first-served basis. Slots are taken up quickly, so please do not delay in submitting an application if you are interested. Each GME program is allotted a maximum of 3 participants per session. In the event that one program has more applicants than slots, we will defer to the program’s leadership to determine which applicants to include.
The annual Methods in Clinical Cancer Research Workshop is a week-long course designed to educate and train early-career investigators in the best practices of clinical trial design and provide access to experienced clinical investigators from different institutions and countries with expertise across all areas of clinical research.
The FDA-AACR Oncology Educational Fellowship is a year-long virtual fellowship on oncology drug development, covering topics such as INDs, NDA/BLA, expedited pathways, endpoints, etc. The sessions will start in the fall and occur approximately monthly, for about 9 months. Last year 20 fellows were accepted.
Oncology product labels contain essential information needed for their safe and effective use. However, many are unfamiliar with the product labels, what information is contained in them, and how to use them. Project Livin’ Label is a new educational initiative that aims to foster broad understanding of the associated oncology product label and increase awareness of recent oncology drug FDA approvals in the cancer community.
The FDA/ASCO Fellows’ Day workshop is a hybrid experience with participants choosing to apply for either virtual or in-person participation. If selected for in-person participation, ASCO will provide a reimbursement of up to $500 to defray the costs of transportation and lodging.
The Workshop is intended to support fellows interested in drug development by providing an introduction to the U.S. Food and Drug Administration (FDA), clinical trial design, oncology drug regulatory science and the drug/device approval process.
The workshop is held twice a year, with a half-day learning curriculum. ASCO usually announces these on their website and sends emails to training program directors.
Project Renewal is a public health initiative established by the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) that aims to update the labeling information for oncology products by evaluating relevant scientific evidence from published literature.
This initiative established a set of repeatable processes and procedures to inform regulatory decisions for oncology product labeling updates, including potential new indications for use.
Aligned with the FDA’s mission to protect public health, this initiative is an opportunity to transparently collaborate with external stakeholders in the evaluation of scientific evidence to inform clinical decisions and patient care.
The goal of Project Socrates is to build an educational network bridging the OCE and the public, focusing on regulatory policy and science. Through partnerships with professional societies, the OCE hopes to extend the breadth of its educational outreach and engagement.
This nomination-only program is open to all oncology fellows and finishing-fellows. GRACE’s designated committee will review the nominees and select up to 4 participants. Nominees for this program will include those still in fellowship and embarking on their post-fellowship junior faculty or practice opportunities; however, it is required that they are still a fellow at the time of the deadline.
Adequate research funding is key to furthering developments in lung cancer treatment. Through partnering with foundations, non-profits, corporations and individual donors, the International Lung Cancer Foundation (ILCF) provides multiple funding opportunities each year to facilitate scientific advances and save lives.
The IPPCR course trains registrants on how to effectively and safely conduct clinical research. This course focuses on the spectrum of clinical research and the research process by highlighting bio-statistical and epidemiologic methods, study design, protocol preparation, etc.
The Rocky Mountain Oncology Society (RMOS) is a powerful community of oncologists, nurse practitioners, physician assistants, and other allied health professionals who provide a voice for multidisciplinary cancer care teams and the patients they serve.
RMOS is the largest oncology professional organization in the state. Members rely on us to provide innovative resources to help them stay ahead of the shifting healthcare landscape and challenges that directly impact the high-quality care their patients deserve—both locally and on a national level.
The Society for Immunotherapy of Cancer’s (SITC) Fellowships and Award program was established through the Forward Fund to support the development of young investigators in the field to cultivate the next generation of cancer immunotherapy experts. Since 2014, SITC has committed more than $3 million in fellowship awards to deserving young investigators.
Society for Translational Oncology Fellows' Forum (STOFF) is an intensive 3-day workshop. Bringing together fellows and junior faculty within 5 years of training completion from the leading medical, surgical, radiation, and pediatric oncology groups and subspecialty fellowships STOFF aims to educate these rising stars on issues around and barriers to successful translational cancer research. A distinguished faculty of prominent scientists, clinicians,
ethicists, industry representatives, and biotech investors serve as mentors.
Tuition expenses, meeting materials, travel, housing, and meals will be covered for successful applicants
Applicants must currently be enrolled in an accredited hematology/oncology or subspecialty training program or be junior faculty within 5 years of training completion with a demonstrated commitment to translational cancer research.
Email email@example.com with questions. No partial submissions will be considered.
The T32 Cancer Immunotherapy & Experimental Therapeutics Program Research grant has two training slots for clinical trainees. Research projects must be related to areas of cancer and immunology or immunotherapy.